It should be noted that according to available HER2 status classification in the human breast cancer gene expression studies, the more aggressive HER2-positive breast cancers (also associated with poorer clinical outcome) were found to express higher NR2F1 transcript levels, as compared with HER2-negative breast cancers (that are mostly ER-positive and less aggressive). Here, ESR1 is linked to breast carcinoma.